These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1505404)

  • 21. Cell electrophoretic investigations of peripheral blood lymphocytes during hemodialysis with different membranes.
    Thomaneck U; Falkenhagen D; Brown GS; Schütt W; Travers M; Klinkmann H
    Life Support Syst; 1985; 3 Suppl 1():53-7. PubMed ID: 3879955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. II. Interleukin-1 production.
    Herbelin A; Ureña P; Man NK; Drüeke T; Descamps-Latscha B
    Contrib Nephrol; 1989; 74():79-85. PubMed ID: 2702150
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanisms and kinetics of the synthesis and release of platelet-activating factor (PAF) by polyacrylonitrile membranes.
    Guastoni C; Tetta C; Hoenich NA; Gervasio R; Sereni L; Tessore E; Wratten ML; Civati G
    Clin Nephrol; 1996 Aug; 46(2):132-8. PubMed ID: 8869791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biocompatibility of a new high-permeability modified cellulose membrane for haemodialysis.
    Ward RA; Schaefer RM; Falkenhagen D; Joshua MS; Heidland A; Klinkmann H; Gurland HJ
    Nephrol Dial Transplant; 1993; 8(1):47-53. PubMed ID: 8381935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukopenia with different regenerated haemodialysis membranes.
    Ksiaźek A; Sokołowska G; Marczewski K; Solski J
    Int Urol Nephrol; 1984; 16(1):61-7. PubMed ID: 6724830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eicosanoid release as an indicator of membrane biocompatibility.
    Schultze G; Wagner K; Neumayer HH; Molzahn M
    Contrib Nephrol; 1987; 59():44-50. PubMed ID: 3442987
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes in leukocyte counts using a cellulose acetate membrane (FB-T) during hemodialysis. A comparison with a cuprophane membrane].
    Pak K; Kobira S; Tomoyoshi T; Nishimura N
    Hinyokika Kiyo; 1986 Sep; 32(9):1231-5. PubMed ID: 3812143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biocompatibility and clinical performance of a new modified cellulose membrane.
    Bosch T; Schmidt B; Samtleben W; Gurland HJ
    Clin Nephrol; 1986; 26 Suppl 1():S22-9. PubMed ID: 3829464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell aggregation and apoptosis induced by hemodialysis membranes.
    Carracedo J; Ramirez R; Pintado O; Gomez-Villamandos JC; Martin-Malo A; Rodríguez M; Aljama P
    J Am Soc Nephrol; 1995 Dec; 6(6):1586-91. PubMed ID: 8749684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukopenia, hypoxia, and complement function with different hemodialysis membranes.
    Jacob AI; Gavellas G; Zarco R; Perez G; Bourgoignie JJ
    Kidney Int; 1980 Oct; 18(4):505-9. PubMed ID: 7230613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and ex vivo blood compatibility study of 2-methacryloyloxyethyl phosphorylcholine (MPC) copolymer-coated hemodialysis hollow fibers.
    Iwasaki Y; Nakabayashi N; Ishihara K
    J Artif Organs; 2003; 6(4):260-6. PubMed ID: 14691668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodialysis effect on platelet count and function and hemodialysis-associated thrombocytopenia.
    Daugirdas JT; Bernardo AA
    Kidney Int; 2012 Jul; 82(2):147-57. PubMed ID: 22592187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal leucocyte locomotion induced by haemodialysis membranes. A clue to dialysis leucopenia.
    Losito A; Buoncristiani U; Cecchini C
    J Clin Lab Immunol; 1983 Feb; 10(2):87-90. PubMed ID: 6601717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of haemodialysis membrane biocompatibility by parallel assessment in an ex vivo model in healthy volunteers.
    Mulvihill J; Crost T; Renaux JL; Cazenave JP
    Nephrol Dial Transplant; 1997 Sep; 12(9):1968-73. PubMed ID: 9306352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemodialysis leucopenia: the role of membrane type and re-use.
    Hoenich NA; Johnston SR; Woffindin C; Kerr DN
    Contrib Nephrol; 1984; 37():120-8. PubMed ID: 6713864
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro investigation of the blood response to medical grade PVC and the effect of heparin on the blood response.
    Lamba NM; Courtney JM; Gaylor JD; Lowe GD
    Biomaterials; 2000 Jan; 21(1):89-96. PubMed ID: 10619682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of blood biocompatibility during haemodialysis with cuprophane and polyacrylonitrile membranes.
    Seyfert UT; Helmling E; Hauck W; Skroch D; Albert W
    Nephrol Dial Transplant; 1991; 6(6):428-34. PubMed ID: 1876284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypersensitivity reactions to synthetic haemodialysis membranes — an emerging issue?
    Alvarez-de Lara MA; Martín-Malo A
    Nefrologia; 2014 Nov; 34(6):698-702. PubMed ID: 25415569
    [No Abstract]   [Full Text] [Related]  

  • 39. Using AN69 ST membrane: a dialysis centre experience.
    Maheut H; Lacour F
    Nephrol Dial Transplant; 2001 Jul; 16(7):1519-20. PubMed ID: 11427664
    [No Abstract]   [Full Text] [Related]  

  • 40. Hemodialysis leukopenia and complement function with different dialyzers.
    Amadori A; Candi P; Sasdelli M; Massai G; Favilla S; Passaleva A; Ricci M
    Kidney Int; 1983 Dec; 24(6):775-81. PubMed ID: 6562280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.